These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 26201949)
1. Needle detachment in a slim and physically active child with insulin pump treatment. Moser C; Maurer K; Binder E; Meraner D; Steichen E; Abt D; Freund-Unsinn K; Hofer SE Pediatr Diabetes; 2016 Aug; 17(5):385-388. PubMed ID: 26201949 [TBL] [Abstract][Full Text] [Related]
2. Two case reports of retained steel insulin pump infusion set needles. Plager P; Murati MA; Moran A; Sunni M Pediatr Diabetes; 2016 Mar; 17(2):160-3. PubMed ID: 25683199 [TBL] [Abstract][Full Text] [Related]
3. Family perceptions of insulin pump adverse events in children and adolescents. Wheeler BJ; Donaghue KC; Heels K; Ambler GR Diabetes Technol Ther; 2014 Apr; 16(4):204-7. PubMed ID: 24313790 [TBL] [Abstract][Full Text] [Related]
4. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1]. Jarosz-Chobot P Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073 [TBL] [Abstract][Full Text] [Related]
5. Needle detachment from the Sure-T infusion set in two young children with diabetes mellitus (DM) treated with continuous subcutaneous insulin infusion (CSII) and unexplained hyperglycaemia. Massa G; Gys I; Eyndt AO; Wauben K; Vanoppen A J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):237-9. PubMed ID: 25153227 [TBL] [Abstract][Full Text] [Related]
6. Insulin pump-associated adverse events in children and adolescents--a prospective study. Wheeler BJ; Heels K; Donaghue KC; Reith DM; Ambler GR Diabetes Technol Ther; 2014 Sep; 16(9):558-62. PubMed ID: 24796368 [TBL] [Abstract][Full Text] [Related]
7. Insulin pump treatment; increasing prevalence, and predictors for better metabolic outcome in Danish children and adolescents with type 1 diabetes. Olsen B; Johannesen J; Fredheim S; Svensson J; Pediatr Diabetes; 2015 Jun; 16(4):256-62. PubMed ID: 25082292 [TBL] [Abstract][Full Text] [Related]
8. Frequency of dermatological side effects of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes. Binder E; Lange O; Edlinger M; Meraner D; Abt D; Moser C; Steichen E; Hofer SE Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):260-4. PubMed ID: 25607337 [TBL] [Abstract][Full Text] [Related]
9. Fulfilling the promise of insulin pump therapy in childhood diabetes. Tamborlane WV Pediatr Diabetes; 2006 Aug; 7 Suppl 4():4-10. PubMed ID: 16774611 [TBL] [Abstract][Full Text] [Related]
10. An angled insertion technique using 6-mm needles markedly reduces the risk of intramuscular injections in children and adolescents. Hofman PL; Lawton SA; Peart JM; Holt JA; Jefferies CA; Robinson E; Cutfield WS Diabet Med; 2007 Dec; 24(12):1400-5. PubMed ID: 18042081 [TBL] [Abstract][Full Text] [Related]
11. [Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion]. Szypowska A; Pańkowska E; Lipka M Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):45-50. PubMed ID: 16704861 [TBL] [Abstract][Full Text] [Related]
12. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus]. Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for discontinuation of insulin pump therapy in pediatric and young adult patients. Kostev K; Rockel T; Rosenbauer J; Rathmann W Prim Care Diabetes; 2014 Dec; 8(4):346-51. PubMed ID: 24735947 [TBL] [Abstract][Full Text] [Related]
14. Analysis of insulin pump settings in children and adolescents with type 1 diabetes mellitus. Lau YN; Korula S; Chan AK; Heels K; Krass I; Ambler G Pediatr Diabetes; 2016 Aug; 17(5):319-26. PubMed ID: 25998469 [TBL] [Abstract][Full Text] [Related]
15. [Treatment of insulin-dependent diabetes mellitus by insulin pump in children under 7 years of age]. Joseph MG; Ginies JL; Chomienne F; Limal JM Arch Fr Pediatr; 1992; 49(6):505-10. PubMed ID: 1449351 [TBL] [Abstract][Full Text] [Related]
17. Insulin pump therapy in children with type 1 diabetes: analysis of data from the SWEET registry. Szypowska A; Schwandt A; Svensson J; Shalitin S; Cardona-Hernandez R; Forsander G; Sundberg F; De Beaufort C; Maahs D; Maffeis C; O'Riordan SM; Krisane ID; Scharf M; Castro S; Konstantinova M; Obermannova B; Casteels K; Gökşen D; Galhardo J; Kanaka-Gantenbein C; Rami-Merhar B; Madacsy L; Pediatr Diabetes; 2016 Oct; 17 Suppl 23():38-45. PubMed ID: 27417128 [TBL] [Abstract][Full Text] [Related]
18. Long-term benefits of continuous subcutaneous insulin infusion in children with Type 1 diabetes: a 4-year follow-up. Sulli N; Shashaj B Diabet Med; 2006 Aug; 23(8):900-6. PubMed ID: 16911629 [TBL] [Abstract][Full Text] [Related]
19. Intramuscular risk at insulin injection sites--measurement of the distance from skin to muscle and rationale for shorter-length needles for subcutaneous insulin therapy. Hirsch L; Byron K; Gibney M Diabetes Technol Ther; 2014 Dec; 16(12):867-73. PubMed ID: 25329935 [TBL] [Abstract][Full Text] [Related]
20. [Personal insulin pumps--from experiment research till recommended method of diabetes treatment]. Mozdzan M; Ruxer J; Loba J Pol Merkur Lekarski; 2005 Oct; 19(112):577-9. PubMed ID: 16379330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]